Showing results (1-10 of 49) with videos related to
Sort By:
Pageof 5
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 24, 2009
Inhibition of renin-angiotensin system attenuates periadventitial inflammation and reduces atherosclerotic lesion formationDaiju Fukuda, Soichiro Enomoto, Ryozo Nagai, et al.European Heart Journal. Case Reports|December 4, 2023
In vivo optical coherence tomography visualisation of coronary artery embolism caused by BioGlue in a middle-aged woman with Marfan syndrome who underwent the Bentall procedure: a case reportYukihiro Hamaguchi, Soichiro Enomoto, Hirokazu Kondo, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 26, 2010
The angiotensin receptor blocker, telmisartan, reduces and stabilizes atherosclerosis in ApoE and AT1aR double deficient miceDaiju Fukuda, Soichiro Enomoto, Yoichiro Hirata, et al.European Journal of Pharmacology|April 18, 2009
Fluvastatin accelerates re-endothelialization impaired by local sirolimus treatmentDaiju Fukuda, Soichiro Enomoto, Ibuki Shirakawa, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 29, 2007
Rosuvastatin prevents endothelial cell death and reduces atherosclerotic lesion formation in ApoE-deficient miceSoichiro Enomoto, Masataka Sata, Daiju Fukuda, et al.Journal of Vascular Surgery|December 4, 2009
Long-term patency of small-diameter vascular graft made from fibroin, a silk-based biodegradable materialSoichiro Enomoto, Makoto Sumi, Kan Kajimoto, et al.Journal of Pharmacological Sciences|September 23, 2006
Effects of treatment for diabetes mellitus on circulating vascular progenitor cellsTakanori Kusuyama, Takashi Omura, Daisuke Nishiya, et al.Journal of Biomaterials Science. Polymer Edition|June 19, 2010
Development of Small-Diameter Vascular Grafts Based on Silk Fibroin Fibers from Bombyx mori for Vascular RegenerationYasumoto Nakazawa, Michiko Sato, Rui Takahashi, et al.Journal of Pharmacological Sciences|August 8, 2006
The effects of HMG-CoA reductase inhibitor on vascular progenitor cellsTakanori Kusuyama, Takashi Omura, Daisuke Nishiya, et al.Journal of Pharmacological Sciences|April 6, 2007
The long-acting Ca2+-channel blocker azelnidipine prevents left ventricular remodeling after myocardial infarctionDaisuke Nishiya, Soichiro Enomoto, Takashi Omura, et al.Pageof 5